Martin Edwards serves as Executive at Verona Pharma plc, where they oversee executive responsibilities. Since joining the company, Martin Edwards has executed 16 insider transactions totaling $276.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 7, 2025 involved exercising options for 72,000 shares valued at $0.
Martin Edwards currently holds 72,000 shares of Verona Pharma plc (VRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin Edwards has been a net seller of VRNA stock. They have purchased $110.9K and sold $165.7K worth of shares.
Martin Edwards's most recent insider trade was on Oct 7, 2025, when they sold 72,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 7, 2025 | VRNA | $0 | Disposition | 157,992 | $N/A | Discretionary |
| Aug 1, 2025 | VRNA | $142.0K | Sale | 10,808 | $13.14 | Discretionary |
| Aug 1, 2025 | VRNA | $0 | Option Exercise | 24,000 | $N/A | Discretionary |
| Aug 16, 2024 | MORF | $0 | Disposition | 2,376 | $N/A | Discretionary |
| Nov 20, 2023 | VRNA | $62.1K | Purchase | 33,736 | $1.84 | Discretionary |
| Nov 13, 2023 | MORF | $48.8K | Purchase | 2,376 | $20.54 | Discretionary |
| Sep 26, 2023 | RETA | $0 | Disposition | 6,116 | $N/A | Discretionary |
| Jun 7, 2023 | RETA | $157.5K | Award | 1,682 | $93.61 | Discretionary |
| Jun 7, 2023 | RETA | $12.5K | Award | 133 | $93.61 | Discretionary |
| Jun 8, 2022 | RETA | $135.0K | Award | 3,883 | $34.76 | Discretionary |
| Jun 8, 2022 | RETA | $12.5K | Award | 359 | $34.76 | Discretionary |
| Jan 3, 2022 | RETA | $1.6K | Award | 59 | $27.32 | Discretionary |
| May 4, 2021 | VRNA | $10.1K | Sale | 12,024 | $0.84 | Discretionary |
| Feb 1, 2021 | VRNA | $13.6K | Sale | 13,688 | $0.99 | Discretionary |